• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Use of Antibiotics at the End of Life: A Cross-Sectional Study.临终时抗生素的使用:一项横断面研究。
Health Serv Insights. 2024 Sep 15;17:11786329241280812. doi: 10.1177/11786329241280812. eCollection 2024.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Sexual Harassment and Prevention Training性骚扰与预防培训
4
Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care.生物标志物作为即时检测手段,指导初级保健中急性呼吸道感染患者使用抗生素的处方。
Cochrane Database Syst Rev. 2022 Oct 17;10(10):CD010130. doi: 10.1002/14651858.CD010130.pub3.
5
Delayed antibiotics for symptoms and complications of respiratory infections.针对呼吸道感染症状及并发症延迟使用抗生素。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD004417. doi: 10.1002/14651858.CD004417.pub2.
6
Immediate versus delayed versus no antibiotics for respiratory infections.即刻与延迟用与不用抗生素治疗呼吸道感染。
Cochrane Database Syst Rev. 2023 Oct 4;10(10):CD004417. doi: 10.1002/14651858.CD004417.pub6.
7
Interventions to improve antibiotic prescribing practices for hospital inpatients.改善医院住院患者抗生素处方行为的干预措施。
Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4.
8
Delayed antibiotic prescriptions for respiratory infections.呼吸道感染的延迟抗生素处方
Cochrane Database Syst Rev. 2017 Sep 7;9(9):CD004417. doi: 10.1002/14651858.CD004417.pub5.
9
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
10
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.

引用本文的文献

1
Response to the Letter to the Editor Regarding "The Use of Antibiotics at the End of Life: A Cross-Sectional Study".对致编辑的信的回复,信的主题为“临终时抗生素的使用:一项横断面研究”
Health Serv Insights. 2025 Jun 11;18:11786329251346225. doi: 10.1177/11786329251346225. eCollection 2025.
2
Redefining Antibiotic Use in Palliative Care: Insights From End-of-Life Prescribing Patterns.重新定义姑息治疗中的抗生素使用:临终处方模式的见解
Health Serv Insights. 2025 Mar 20;18:11786329251324842. doi: 10.1177/11786329251324842. eCollection 2025.

本文引用的文献

1
Executive Summary: State-of-the-Art Review: Use of Antimicrobials at the End of Life.执行摘要:最新综述:临终时抗菌药物的使用
Clin Infect Dis. 2024 Mar 20;78(3):493-495. doi: 10.1093/cid/ciad737.
2
End-of-Life Antibiotherapy: Factors Associated With Prescription.临终抗生素治疗:与处方相关的因素
Cureus. 2022 Nov 18;14(11):e31634. doi: 10.7759/cureus.31634. eCollection 2022 Nov.
3
End-of-life use of antibiotics: a survey on how doctors decide.临终时使用抗生素:医生如何决策的调查。
Int J Infect Dis. 2022 Jan;114:219-225. doi: 10.1016/j.ijid.2021.10.026. Epub 2021 Oct 17.
4
Appropriate Use of Ceftriaxone in Sub-Saharan Africa: A Systematic Review.头孢曲松在撒哈拉以南非洲地区的合理使用:一项系统评价。
Infect Drug Resist. 2021 Aug 28;14:3477-3484. doi: 10.2147/IDR.S329996. eCollection 2021.
5
Antibiotic use towards the end of life: development of good practice recommendations.临终时抗生素的使用:制定良好实践建议。
BMJ Support Palliat Care. 2021 Jan 19. doi: 10.1136/bmjspcare-2020-002732.
6
Antibiotic use during end-of-life care: A systematic literature review and meta-analysis.临终关怀期间的抗生素使用:系统文献回顾和荟萃分析。
Infect Control Hosp Epidemiol. 2021 May;42(5):523-529. doi: 10.1017/ice.2020.1241. Epub 2020 Nov 11.
7
Impact of Inappropriate Antibiotic Therapy in Vancomycin-Resistant Enterococcus Bacteremia.万古霉素耐药肠球菌菌血症中不适当抗生素治疗的影响。
Am J Ther. 2020 Sep 4;28(4):e388-e396. doi: 10.1097/MJT.0000000000001127.
8
Palliative care infections and antibiotic cost: a vicious circle.姑息治疗相关感染与抗生素费用:恶性循环。
Aging Male. 2020 Jun;23(2):98-105. doi: 10.1080/13685538.2019.1575353. Epub 2019 Mar 1.
9
Antimicrobial use in patients at the end of life in an Australian hospital.澳大利亚一家医院中临终患者的抗菌药物使用情况。
Infect Dis Health. 2019 May;24(2):92-97. doi: 10.1016/j.idh.2018.12.001. Epub 2019 Jan 14.
10
Antimicrobial therapy in palliative care: an overview.姑息治疗中的抗菌治疗:概述。
Support Care Cancer. 2018 May;26(5):1361-1367. doi: 10.1007/s00520-018-4090-8. Epub 2018 Feb 12.

临终时抗生素的使用:一项横断面研究。

The Use of Antibiotics at the End of Life: A Cross-Sectional Study.

作者信息

Miranda-Chavez Brayan, Fuentes-Yufra Andre, Hueda-Zavaleta Miguel, Copaja-Corzo Cesar, Flores-Cohaila Javier A, Rivarola-Hidalgo Marco

机构信息

Facultad de Ciencias de la Salud, Universidad Privada de Tacna, Tacna, Peru.

Centro de Estudios e Investigación en Educación Médica y Bioética. Universidad Privada de Tacna. Tacna, Perú.

出版信息

Health Serv Insights. 2024 Sep 15;17:11786329241280812. doi: 10.1177/11786329241280812. eCollection 2024.

DOI:10.1177/11786329241280812
PMID:39286265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11403560/
Abstract

OBJECTIVE

To identify and analyze antibiotics' prescription patterns and associated factors among terminally ill patients at a hospital in southern Peru.

METHODOLOGY

A cross-sectional analytical study was conducted on adult patients who died in Hospital III Daniel Alcides Carrion in Tacna, Peru, 2023. Data were collected from electronic medical records, focusing on antibiotic use during the last hospitalization. Univariate, bivariate, and multivariate analyses were performed using Poisson regression to adjust for potential confounders.

RESULTS

The study included 239 patients with an average age of 76. Antibiotics were administered to 93.72% of patients, with 42.46% lacking an identified infectious focus. Ceftriaxone, Meropenem, and Vancomycin were the most used antibiotics. A lower use of antibiotics within 72 hours prior to death was associated with hospitalizations longer than 18 days and having 2 or more comorbidities.

CONCLUSION

The high prevalence of antibiotic use at the end of life, often without an infectious focus, suggests a need for better guidelines and education on palliative care to avoid inappropriate antibiotic prescribing. Improved communication between healthcare providers, patients, and families is essential for optimizing end-of-life care.

摘要

目的

识别并分析秘鲁南部一家医院临终患者的抗生素处方模式及相关因素。

方法

对2023年在秘鲁塔克纳市丹尼尔·阿尔西德斯·卡里翁三世医院死亡的成年患者进行了一项横断面分析研究。从电子病历中收集数据,重点关注最后一次住院期间的抗生素使用情况。使用泊松回归进行单变量、双变量和多变量分析,以调整潜在的混杂因素。

结果

该研究纳入了239名平均年龄为76岁的患者。93.72%的患者使用了抗生素,其中42.46%的患者未发现明确的感染病灶。头孢曲松、美罗培南和万古霉素是使用最多的抗生素。死亡前72小时内抗生素使用量较低与住院时间超过18天以及患有2种或更多合并症有关。

结论

临终时抗生素使用率高,且往往没有感染病灶,这表明需要更好的姑息治疗指南和教育,以避免不适当的抗生素处方。医疗服务提供者、患者和家属之间加强沟通对于优化临终关怀至关重要。